Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability To AYON Body Contouring System

Published: 2026-05-11 11:52:57 ET APYX

Published on 05/11/2026 at 11:52 am EDT

Apyx Medical Corporation received expanded 510(k) clearance from the U.S. Food and Drug Administration for the AYON Body Contouring System to include power liposuction, an advanced form of liposuction that uses a reciprocating cannula to enhance efficiency of fat removal to reduce a surgeon?s effort and operating room time. By integrating power liposuction into a single, unified platform, surgeons are enabled to perform multiple critical body contouring modalities within one system?streamlining workflow, improving procedural efficiency, and supporting optimal patient outcomes. AYON is a groundbreaking, surgeon-designed body contouring system that combines precision, versatility, and innovation in an all-in-one platform.

It seamlessly integrates fat removal, closed loop contouring, and Renuvion?s tissue contraction and electrosurgical capabilities, empowering surgeons to deliver the most comprehensive body contouring treatments for patients. With advanced features like LIFT Technology for real-time adjustments and Renuvion for enhanced tissue contraction, AYON sets a new standard in surgical care, streamlining procedures and maximizing patient outcomes. AYON delivers consistent, reliable performance and an unmatched return on investment.

In October 2025, the Company filed an additional 510(k) for the label expansion of AYON to include power liposuction.